PROVIDERS

NanoBone is a bone graft substitute consisting of nanocrystals of hydroxyapatite (HA) bioidentical to human bone, dispersed in an amorphous silica gel matrix (ASG).

NanoBone Brochure

NanoBone Technology

Bioidentical to human bone
Forms a composite with ASG
NanoBone HA has 40x surface area of other HA-based bone grafts

ASG

Initiates Clotting Factor XII
Triggers angiogenesis and new bone formation
Rapidly replaced by an autologous organic matrix

Autologous organic matrix initiates cell-mediated bone formation and resorption

Technology Monograph

"I have complete confidence in arthrodesis achieved in a timely fashion with NanoBone with no threat of overgrowth or reactive airway marrow soft tissue associated with the biologics.”

Michael Schneier, MD,

Neurosurgical Consulting,

Las Vegas, NV

FEATURED CASE STUDIES

Scoliosis Fusion - Hoernschemeyer

Adolescent Idiopathic Scoliosis treated with posterior fusion and NanoBone

View Now

Foot reconstruction - McAlister

Surgical repair of failed cavovarus foot reconstruction

View Now

Post Cervical Fusion - Udani

Posterolateral use of nanocrystalline hydroxyapatite in prior multilevel ACDF patient

View Now

Case Study Archives

FEATURED CLINICAL ABSTRACT SUMMARIES

Rosenthal, H. Evaluating a Nanocrystalline Hydroxyapatite Bone Graft Substitute for the Treatment of Benign Bone Tumors. The Internet Journal of Orthopedic Surgery. 2022 Volume 30 Number 1, 1-5.

View Now

Wang, W., et al.,
Bone grafts and biomaterials substitutes for bone defect repair: A review.
Bioactive Materials.
2017; 2(4),
224-247.

View Now

Abedi, A. et al., Examination of the Role of Cells in Commercially Available Cellular Allografts in Spine Fusion. An in Vivo Animal Study, The Journal of Bone and Joint Surgery. 2020; 102(24):p e135.

View Now